日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced Efficiency of the Microsomal Prostaglandin E(2) Synthase-1 Inhibitor AGU661 in Human Whole Blood by Encapsulation into PLGA-Based Nanoparticles

通过将微粒体前列腺素E(2)合成酶-1抑制剂AGU661封装到PLGA基纳米颗粒中,提高了其在人全血中的效率

Dahlke, Philipp; Jordan, Paul M; Klepsch, Lea C; Ergül, Azize Gizem; Stumpf, Steffi; Hoeppener, Stephanie; Vollrath, Antje; Çalışkan, Burcu; Banoglu, Erden; Schubert, Ulrich S; Werz, Oliver

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer

靶向TACC3可诱导免疫原性细胞死亡并增强HER2阳性乳腺癌中T-DM1的反应

Gedik, Mustafa Emre; Saatci, Ozge; Oberholtzer, Nathaniel; Uner, Meral; Akbulut Caliskan, Ozge; Cetin, Metin; Aras, Mertkaya; Ibis, Kubra; Caliskan, Burcu; Banoglu, Erden; Wiemann, Stefan; Üner, Ayşegül; Aksoy, Sercan; Mehrotra, Shikhar; Sahin, Ozgur

Correction: Encapsulation of the dual FLAP/mPEGS‑1 inhibitor BRP‑187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity

更正:将双重 FLAP/mPEGS-1 抑制剂 BRP-187 封装到缩醛化葡聚糖和 PLGA 纳米颗粒中可提高其细胞生物活性。

Shkodra, Blerina; Kretzer, Christian; Jordan, Paul M; Klemm, Paul; Koeberle, Andreas; Pretzel, David; Banoglu, Erden; Lorkowski, Stefan; Wallert, Maria; Höppener, Stephanie; Stumpf, Steffi; Vollrath, Antje; Schubert, Stephanie; Werz, Oliver; Schubert, Ulrich S

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

靶向TACC3代表了中心体扩增型高侵袭性乳腺癌的一种新型治疗靶点。

Saatci, Ozge; Akbulut, Ozge; Cetin, Metin; Sikirzhytski, Vitali; Uner, Meral; Lengerli, Deniz; O'Quinn, Elizabeth C; Romeo, Martin J; Caliskan, Burcu; Banoglu, Erden; Aksoy, Sercan; Uner, Aysegul; Sahin, Ozgur

Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein

取代的 1,2,4-三唑作为靶向 5-脂氧合酶活化蛋白的新型选择性白三烯生物合成抑制剂

Abdurrahman Olğaç, İrfan Çapan, Philipp Dahlke, Paul M Jordan, Oliver Werz, Erden Banoglu

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

苯并恶唑酮-5-尿素衍生物作为人可溶性环氧化物水解酶 (sEH) 抑制剂

Tugce Gur Maz, Beyzanur Koc, Paul M Jordan, Kübra İbiş, Burcu Çalışkan, Oliver Werz, Erden Banoglu

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

靶向TACC3可恢复免疫原性细胞死亡,从而增强HER2阳性乳腺癌中T-DM1的反应。

Gedik, Mustafa Emre; Saatci, Ozge; Oberholtzer, Nathaniel; Uner, Meral; Akbulut, Ozge; Cetin, Metin; Aras, Mertkaya; Ibis, Kubra; Caliskan, Burcu; Banoglu, Erden; Wiemann, Stefan; Uner, Aysegul; Aksoy, Sercan; Mehrotra, Shikhar; Sahin, Ozgur

Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

5-脂氧合酶激活蛋白(FLAP)拮抗剂BRP-201将白三烯的生物合成转向特异性促消解介质

Christian Kretzer ,Paul M Jordan ,Rossella Bilancia ,Antonietta Rossi ,Tuğçe Gür Maz ,Erden Banoglu ,Ulrich S Schubert ,Oliver Werz

Quinazoline-4(3 H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition

喹唑啉-4(3H)-酮-7-甲酰胺衍生物作为人可溶性环氧化物水解酶抑制剂,具有可发展的5-脂氧合酶活化蛋白抑制作用

Sümeyye Turanlı, Azize Gizem Ergül, Paul M Jordan, Abdurrahman Olğaç, Burcu Çalışkan, Oliver Werz, Erden Banoglu

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

具有体外生长抑制和体内抗肿瘤活性的邻位二芳基取代异恶唑和吡唑衍生物

Sümeyye Turanlı, Esra Nalbat, Deniz Lengerli, Kübra İbiş, Sezen Güntekin Ergün, Ece Akhan Güzelcan, Mesut Muyan, Rengul Cetin-Atalay, Burcu Çalışkan, Erden Banoglu